-
FDA approves new schizophrenia drug
SILVER SPRING, Md. The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.
The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.
-
Jaeger is a smart choice for the NCPA
WHAT IT MEANS AND WHY IT'S IMPORTANT The natural affinity that has sprung up between independent pharmacy and the generic drug industry -- both viewed as underdogs in the relentless fight for market position and profits: one versus powerful chain and big-box retailers, the other versus the far more entrenched and well-funded branded drug industry -- was never more fully realized than it was last weekend, when the National Community Pharmacists Association introduced its new top manager to its members at the group’s annual meeting.
